Veröffentlichungen

  • Chlamydia pneumoniae GroEL1 protein is cell surface associated and required for infection of HEp-2 cells. Wuppermann FN, Mölleken K, Julien M, Jantos CA, Hegemann JH. J Bacteriol. 2008 May;190(10):3757-67. Epub 2008 Feb 29.

  • Chlamydia pneumoniae is not detectable in subretinal neovascular membranes in the exudative stage of age-related macular degeneration. Kessler W, Jantos CA, Dreier J, Pavlovic S. Acta Ophthalmol Scand. 2006 Jun;84(3):333-7.

  • Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. Wuppermann FN, Hegemann JH, Jantos CA. J Infect Dis. 2001 Jul 15;184(2):181-7. Epub 2001 Jun 5.

  • Infection and activation of airway epithelial cells by Chlamydia pneumoniae. Jahn HU, Krüll M, Wuppermann FN, Klucken AC, Rosseau S, Seybold J, Hegemann JH, Jantos CA, Suttorp N. J Infect Dis. 2000 Dec;182(6):1678-87. Epub 2000 Oct 18.

  • A search for beta-lactamase in chlamydiae, mycoplasmas, planctomycetes, and cyanelles: bacteria and bacterial descendants at different phylogenetic positions and stages of cell wall development. Claus H, Martin HH, Jantos CA, König H. Microbiol Res. 2000 Apr;155(1):1-6.

  • Chlamydia pneumoniae infection is not an independent risk factor for arterial disease. Haberbosch W, Jantos C. Herz. 2000 Mar;25(2):79-83. Review.

  • Antibody response to the 60-kDa heat-shock protein of Chlamydia pneumoniae in patients with coronary artery disease. Jantos CA, Krombach C, Wuppermann FN, Gardemann A, Bepler S, Asslan H, Hegemann JH, Haberbosch W. J Infect Dis. 2000 May;181(5):1700-5. Epub 2000 May 15.

  • Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. Jantos CA, Nesseler A, Waas W, Baumgärtner W, Tillmanns H, Haberbosch W. Clin Infect Dis. 1999 May;28(5):988-92.

  • Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae. Krüll M, Klucken AC, Wuppermann FN, Fuhrmann O, Magerl C, Seybold J, Hippenstiel S, Hegemann JH, Jantos CA, Suttorp N. J Immunol. 1999 Apr 15;162(8):4834-41.

  • Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay. Jantos CA, Roggendorf R, Wuppermann FN, Hegemann JH. J Clin Microbiol. 1998 Jul;36(7):1890-4.

  • Experimental genital tract infection with Chlamydia psittaci (GPIC agent) in male rats. Jantos CA, Augustin J, Durchfeld-Meyer B, Baumgärtner W, Schiefer HG. Infection. 1998 Mar-Apr;26(2):126-30.

  • Tissue penetration of sparfloxacin in a rat model of experimental Escherichia coli epididymitis. Ludwig M, Jantos CA, Wolf S, Bergmann M, Failing K, Schiefer HG, Weidner W. Infection. 1997 May-Jun;25(3):178-84.

  • Antigenic and molecular analyses of different Chlamydia pneumoniae strains. Jantos CA, Heck S, Roggendorf R, Sen-Gupta M, Hegemann JH. J Clin Microbiol. 1997 Mar;35(3):620-3.

  • Infection with Chlamydia pneumoniae in infants and children with acute lower respiratory tract disease. Jantos CA, Wienpahl B, Schiefer HG, Wagner F, Hegemann JH. Pediatr Infect Dis J. 1995 Feb;14(2):117-22.

  • [Urethro-adnexitis in the man and acute urethral syndrome in the woman. Microbiological and immunologic studies of etiologic classification]. Schiefer HG, Jantos C, Weidner W. Urologe A. 1994 May;33(3):188-95. Review. German.

  • Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats. Vieler E, Jantos C, Schmidts HL, Weidner W, Schiefer HG. Antimicrob Agents Chemother. 1993 Apr;37(4):846-50.

  • Immuno-competent cells in the murine epididymis following infection with Escherichia coli. Nashan D, Jantos C, Ahlers D, Bergmann M, Schiefer HG, Sorg C, Nieschlag E. Int J Androl. 1993 Feb;16(1):47-52.

  • Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany. Jantos C, Artelt P, Schiefer HG. Eur J Clin Microbiol Infect Dis. 1993 Jan;12(1):33-5.

  • Experimental epididymitis due to Chlamydia trachomatis in rats. Jantos C, Baumgärtner W, Durchfeld B, Schiefer HG. Infect Immun. 1992 Jun;60(6):2324-8.

  • Semen parameters in men with and without proven chronic prostatitis.Weidner W, Jantos C, Schiefer HG, Haidl G, Friedrich HJ.Arch Androl. 1991 May-Jun;26(3):173-83.

  • Recurrent haemospermia--underlying urogenital anomalies and efficacy of imaging procedures. Weidner W, Jantos C, Schumacher F, Schiefer HG, Meyhöfer W. Br J Urol. 1991 Mar;67(3):317-23.

  • Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M. Infection. 1991;19 Suppl 3:S119-25. No abstract available.

  • Acute and chronic bacterial prostatitis due to E. coli. Description of an animal model. Jantos C, Altmannsberger M, Weidner W, Schiefer HG. Urol Res. 1990;18(3):207-11.

  • Experimental chlamydial epididymitis. Jantos C, Krauss H, Altmannsberger M, Thiele D, Weidner W, Schiefer HG. Urol Int. 1989;44(5):279-83.

  • [Long-term experiences with autoinjection therapy of papaverine in erectile dysfunction]. Jantos C, Krause W, Kauss E, Weidner W. Urologe A. 1988 Jan;27(1):18-21. German.

  • Pharmacocavernosography in the evaluation of erectile failure. Jantos C, Weidner W. Urol Int. 1988;43(4):225-30.